{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:01:57Z","timestamp":1790251317314,"version":"4.1.0"},"reference-count":240,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"DOI":"10.1038\/s41581-026-01127-4","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:03:15Z","timestamp":1790247795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular\u2013kidney\u2013metabolic syndrome as a mitochondrial systems disorder"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0154-5170","authenticated-orcid":false,"given":"Shen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Dale","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1368-2453","authenticated-orcid":false,"given":"Zoltan","family":"Arany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8262-6549","authenticated-orcid":false,"given":"Joseph A.","family":"Baur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1924-0333","authenticated-orcid":false,"given":"Liming","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-3726","authenticated-orcid":false,"given":"Katalin","family":"Susztak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"1127_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele, C. E. et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation 148, 1606\u20131635 https:\/\/doi.org\/10.1161\/CIR.0000000000001184 (2023).","journal-title":"Circulation"},{"key":"1127_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/ki.2011.283","volume":"80","author":"A Shankar","year":"2011","unstructured":"Shankar, A. et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int. 80, 1231\u20131238 https:\/\/doi.org\/10.1038\/ki.2011.283 (2011).","journal-title":"Kidney Int."},{"key":"1127_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","volume":"117","author":"GG Schiattarella","year":"2021","unstructured":"Schiattarella, G. G., Rodolico, D. & Hill, J. A. Metabolic inflammation in heart failure with preserved ejection fraction. Cardiovasc. Res. 117, 423\u2013434 https:\/\/doi.org\/10.1093\/cvr\/cvaa217 (2021).","journal-title":"Cardiovasc. Res."},{"key":"1127_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrneph.2013.250","volume":"10","author":"B Braam","year":"2014","unstructured":"Braam, B., Joles, J. A., Danishwar, A. H. & Gaillard, C. A. Cardiorenal syndrome \u2014 current understanding and future perspectives. Nat. Rev. Nephrol. 10, 48\u201355 https:\/\/doi.org\/10.1038\/nrneph.2013.250 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"1127_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero, E. & Maack, C. Metabolic remodelling in heart failure. Nat. Rev. Cardiol. 15, 457\u2013470 https:\/\/doi.org\/10.1038\/s41569-018-0044-6 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"1127_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrm.2016.96","volume":"17","author":"W Wang","year":"2016","unstructured":"Wang, W. & Seale, P. Control of brown and beige fat development. Nat. Rev. Mol. Cell Biol. 17, 691\u2013702 https:\/\/doi.org\/10.1038\/nrm.2016.96 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1127_CR7","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1161\/CIRCRESAHA.122.319989","volume":"130","author":"KP Patel","year":"2022","unstructured":"Patel, K. P., Katsurada, K. & Zheng, H. Cardiorenal syndrome: the role of neural connections between the heart and the kidneys. Circ. Res. 130, 1601\u20131617 https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.319989 (2022).","journal-title":"Circ. Res."},{"key":"1127_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2023.100705","volume":"5","author":"RN Patel","year":"2023","unstructured":"Patel, R. N., Sharma, A., Prasad, A. & Bansal, S. Heart failure with preserved ejection fraction with CKD: a narrative review of a multispecialty disorder. Kidney Med. 5, 100705 https:\/\/doi.org\/10.1016\/j.xkme.2023.100705 (2023).","journal-title":"Kidney Med."},{"key":"1127_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.011173","volume":"17","author":"N Bansal","year":"2024","unstructured":"Bansal, N., Zelnick, L. R., Scherzer, R., Estrella, M. & Shlipak, M. G. Risk factors and outcomes associated with heart failure with preserved and reduced ejection fraction in people with chronic kidney disease. Circ. Heart Fail. 17, e011173 https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.123.011173 (2024).","journal-title":"Circ. Heart Fail."},{"key":"1127_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf784.1432","volume":"46","author":"K Barmpagiannos","year":"2025","unstructured":"Barmpagiannos, K. et al. Predictors and prognostic impact of chronic kidney disease in hospitalized patients with heart failure - insights from the cardiomining study. Eur. Heart J. 46, ehaf784.1432 https:\/\/doi.org\/10.1093\/eurheartj\/ehaf784.1432 (2025).","journal-title":"Eur. Heart J."},{"key":"1127_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli, J. B. & Haigis, M. C. The multifaceted contributions of mitochondria to cellular metabolism. Nat. Cell Biol. 20, 745\u2013754 https:\/\/doi.org\/10.1038\/s41556-018-0124-1 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1127_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrneph.2018.9","volume":"14","author":"JM Forbes","year":"2018","unstructured":"Forbes, J. M. & Thorburn, D. R. Mitochondrial dysfunction in diabetic kidney disease. Nat. Rev. Nephrol. 14, 291\u2013312 https:\/\/doi.org\/10.1038\/nrneph.2018.9 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"1127_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","volume":"13","author":"P Bhargava","year":"2017","unstructured":"Bhargava, P. & Schnellmann, R. G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 13, 629\u2013646 https:\/\/doi.org\/10.1038\/nrneph.2017.107 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"1127_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf784.4737","volume":"46","author":"JM Kneuer","year":"2025","unstructured":"Kneuer, J. M. et al. Comparative immune profiling in HFpEF: cross-species insights into inflammation and mitochondrial dysfunction. Eur. Heart J. 46, ehaf784.4737 https:\/\/doi.org\/10.1093\/eurheartj\/ehaf784.4737 (2025).","journal-title":"Eur. Heart J."},{"key":"1127_CR15","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.cmet.2024.09.003","volume":"36","author":"B Chen","year":"2024","unstructured":"Chen, B. et al. GLP-1 programs the neurovascular landscape. Cell Metab. 36, 2173\u20132189 https:\/\/doi.org\/10.1016\/j.cmet.2024.09.003 (2024).","journal-title":"Cell Metab."},{"key":"1127_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan, W. K. et al. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J. Obes. Metab. Syndr. 32, 197\u2013213 https:\/\/doi.org\/10.7570\/jomes23052 (2023).","journal-title":"J. Obes. Metab. Syndr."},{"key":"1127_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.043173","volume":"14","author":"W Kawaharata","year":"2025","unstructured":"Kawaharata, W. et al. Incorporation of metabolic dysfunction-associated steatotic liver disease in the health stage of cardiovascular-kidney-metabolic syndrome improves predictive ability for coronary artery disease in a Japanese general population. J. Am. Heart Assoc. 14, e043173 https:\/\/doi.org\/10.1161\/JAHA.125.043173 (2025).","journal-title":"J. Am. Heart Assoc."},{"key":"1127_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/biom15020213","volume":"15","author":"N Theodorakis","year":"2025","unstructured":"Theodorakis, N. & Nikolaou, M. From cardiovascular-kidney-metabolic syndrome to cardiovascular-renal-hepatic-metabolic syndrome: proposing an expanded framework. Biomolecules 15, 213 https:\/\/doi.org\/10.3390\/biom15020213 (2025).","journal-title":"Biomolecules"},{"key":"1127_CR19","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J Nunnari","year":"2012","unstructured":"Nunnari, J. & Suomalainen, A. Mitochondria: in sickness and in health. Cell 148, 1145\u20131159 https:\/\/doi.org\/10.1016\/j.cell.2012.02.035 (2012).","journal-title":"Cell"},{"key":"1127_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen, W., Zhao, H. & Li, Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct. Target. Ther. 8, 333 https:\/\/doi.org\/10.1038\/s41392-023-01547-9 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1127_CR21","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","volume":"28","author":"S Pickles","year":"2018","unstructured":"Pickles, S., Vigie, P. & Youle, R. J. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr. Biol. 28, R170\u2013R185 https:\/\/doi.org\/10.1016\/j.cub.2018.01.004 (2018).","journal-title":"Curr. Biol."},{"key":"1127_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41581-020-00369-0","volume":"17","author":"C Tang","year":"2021","unstructured":"Tang, C. et al. Mitochondrial quality control in kidney injury and repair. Nat. Rev. Nephrol. 17, 299\u2013318 https:\/\/doi.org\/10.1038\/s41581-020-00369-0 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"1127_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/CIRCRESAHA.124.323800","volume":"135","author":"A Hinton Jr.","year":"2024","unstructured":"Hinton, A. Jr. et al. Mitochondrial structure and function in human heart failure. Circ. Res. 135, 372\u2013396 https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.323800 (2024).","journal-title":"Circ. Res."},{"key":"1127_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk, G. D., Ussher, J. R., Folmes, C. D., Jaswal, J. S. & Stanley, W. C. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90, 207\u2013258 https:\/\/doi.org\/10.1152\/physrev.00015.2009 (2010).","journal-title":"Physiol. Rev."},{"key":"1127_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37\u201346 https:\/\/doi.org\/10.1038\/nm.3762 (2015).","journal-title":"Nat. Med."},{"key":"1127_CR26","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1681\/ASN.2015020177","volume":"27","author":"R Lan","year":"2016","unstructured":"Lan, R. et al. Mitochondrial pathology and glycolytic shift during proximal tubule atrophy after ischemic AKI. J. Am. Soc. Nephrol. 27, 3356\u20133367 https:\/\/doi.org\/10.1681\/ASN.2015020177 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1127_CR27","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.cmet.2022.09.026","volume":"34","author":"H Li","year":"2022","unstructured":"Li, H., Dixon, E. E., Wu, H. & Humphreys, B. D. Comprehensive single-cell transcriptional profiling defines shared and unique epithelial injury responses during kidney fibrosis. Cell Metab. 34, 1977\u20131998\u00a0https:\/\/doi.org\/10.1016\/j.cmet.2022.09.026 (2022).","journal-title":"Cell Metab."},{"key":"1127_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097898","volume":"24","author":"SK Masenga","year":"2023","unstructured":"Masenga, S. K., Kabwe, L. S., Chakulya, M. & Kirabo, A. Mechanisms of oxidative stress in metabolic syndrome. Int. J. Mol. Sci. 24, 7898 https:\/\/doi.org\/10.3390\/ijms24097898 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1127_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/CIRCRESAHA.114.300559","volume":"114","author":"YR Chen","year":"2014","unstructured":"Chen, Y. R. & Zweier, J. L. Cardiac mitochondria and reactive oxygen species generation. Circ. Res. 114, 524\u2013537 https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.300559 (2014).","journal-title":"Circ. Res."},{"key":"1127_CR30","doi-asserted-by":"publisher","first-page":"H742","DOI":"10.1152\/ajpheart.1994.267.2.H742","volume":"267","author":"MF Allard","year":"1994","unstructured":"Allard, M. F., Schonekess, B. O., Henning, S. L., English, D. R. & Lopaschuk, G. D. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am. J. Physiol. 267, H742\u2013H750 https:\/\/doi.org\/10.1152\/ajpheart.1994.267.2.H742 (1994).","journal-title":"Am. J. Physiol."},{"key":"1127_CR31","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R. & Abel, E. D. Cardiac energy metabolism in heart failure. Circ. Res. 128, 1487\u20131513 https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318241 (2021).","journal-title":"Circ. Res."},{"key":"1127_CR32","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/s12276-023-00967-5","volume":"55","author":"E Kankuri","year":"2023","unstructured":"Kankuri, E. et al. Altered acylcarnitine metabolism and inflexible mitochondrial fuel utilization characterize the loss of neonatal myocardial regeneration capacity. Exp. Mol. Med. 55, 806\u2013817 https:\/\/doi.org\/10.1038\/s12276-023-00967-5 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1127_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015154","volume":"9","author":"J Li","year":"2020","unstructured":"Li, J. et al. Metformin improves cardiac metabolism and function, and prevents left ventricular hypertrophy in spontaneously hypertensive rats. J. Am. Heart Assoc. 9, e015154 https:\/\/doi.org\/10.1161\/JAHA.119.015154 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"1127_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052717","volume":"23","author":"MA Virmani","year":"2022","unstructured":"Virmani, M. A. & Cirulli, M. The role of l-carnitine in mitochondria, prevention of metabolic inflexibility and disease initiation. Int. J. Mol. Sci. 23, 2717 https:\/\/doi.org\/10.3390\/ijms23052717 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1127_CR35","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","volume":"37","author":"R Laaksonen","year":"2016","unstructured":"Laaksonen, R. et al. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur. Heart J. 37, 1967\u20131976 https:\/\/doi.org\/10.1093\/eurheartj\/ehw148 (2016).","journal-title":"Eur. Heart J."},{"key":"1127_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cmet.2025.10.006","volume":"38","author":"RJ Nicholson","year":"2026","unstructured":"Nicholson, R. J. et al. Therapeutic remodeling of the ceramide backbone prevents kidney injury. Cell Metab. 38, 135\u2013156\u00a0https:\/\/doi.org\/10.1016\/j.cmet.2025.10.006 (2026).","journal-title":"Cell Metab."},{"key":"1127_CR37","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00395-025-01136-7","volume":"120","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy. Basic Res. Cardiol. 120, 1193\u20131207 https:\/\/doi.org\/10.1007\/s00395-025-01136-7 (2025).","journal-title":"Basic Res. Cardiol."},{"key":"1127_CR38","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1194\/jlr.M055152","volume":"56","author":"B Jaishy","year":"2015","unstructured":"Jaishy, B. et al. Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity. J. Lipid Res. 56, 546\u2013561 https:\/\/doi.org\/10.1194\/jlr.M055152 (2015).","journal-title":"J. Lipid Res."},{"key":"1127_CR39","doi-asserted-by":"publisher","first-page":"10379","DOI":"10.1074\/jbc.M111.304998","volume":"287","author":"CY Han","year":"2012","unstructured":"Han, C. Y. et al. NADPH oxidase-derived reactive oxygen species increases expression of monocyte chemotactic factor genes in cultured adipocytes. J. Biol. Chem. 287, 10379\u201310393 https:\/\/doi.org\/10.1074\/jbc.M111.304998 (2012).","journal-title":"J. Biol. Chem."},{"key":"1127_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/CIRCRESAHA.117.311307","volume":"122","author":"K Tsushima","year":"2018","unstructured":"Tsushima, K. et al. Mitochondrial reactive oxygen species in lipotoxic hearts induce post-translational modifications of AKAP121, DRP1, and OPA1 that promote mitochondrial fission. Circ. Res. 122, 58\u201373 https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311307 (2018).","journal-title":"Circ. Res."},{"key":"1127_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14070848","volume":"14","author":"J Grujicic","year":"2025","unstructured":"Grujicic, J. & Allen, A. R. Manganese superoxide dismutase: structure, function, and implications in human disease. Antioxidants 14, 848 https:\/\/doi.org\/10.3390\/antiox14070848 (2025).","journal-title":"Antioxidants"},{"key":"1127_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12071445","volume":"12","author":"C Di Giacomo","year":"2023","unstructured":"Di Giacomo, C., Malfa, G. A., Tomasello, B., Bianchi, S. & Acquaviva, R. Natural compounds and glutathione: beyond mere antioxidants. Antioxidants 12, 1445 https:\/\/doi.org\/10.3390\/antiox12071445 (2023).","journal-title":"Antioxidants"},{"key":"1127_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10111824","volume":"10","author":"G Napolitano","year":"2021","unstructured":"Napolitano, G., Fasciolo, G. & Venditti, P. Mitochondrial management of reactive oxygen species. Antioxidants 10, 1824 https:\/\/doi.org\/10.3390\/antiox10111824 (2021).","journal-title":"Antioxidants"},{"key":"1127_CR44","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/JCI120849","volume":"128","author":"B Zhou","year":"2018","unstructured":"Zhou, B. & Tian, R. Mitochondrial dysfunction in pathophysiology of heart failure. J. Clin. Invest. 128, 3716\u20133726 https:\/\/doi.org\/10.1172\/JCI120849 (2018).","journal-title":"J. Clin. Invest."},{"key":"1127_CR45","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1172\/JCI37829","volume":"119","author":"C Brooks","year":"2009","unstructured":"Brooks, C., Wei, Q., Cho, S. G. & Dong, Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J. Clin. Invest. 119, 1275\u20131285 https:\/\/doi.org\/10.1172\/JCI37829 (2009).","journal-title":"J. Clin. Invest."},{"key":"1127_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/cvr\/cvn184","volume":"80","author":"MG Rosca","year":"2008","unstructured":"Rosca, M. G. et al. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc. Res. 80, 30\u201339 https:\/\/doi.org\/10.1093\/cvr\/cvn184 (2008).","journal-title":"Cardiovasc. Res."},{"key":"1127_CR47","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1681\/ASN.2017060659","volume":"29","author":"HM Perry","year":"2018","unstructured":"Perry, H. M. et al. Dynamin-related protein 1 deficiency promotes recovery from AKI. J. Am. Soc. Nephrol. 29, 194\u2013206 https:\/\/doi.org\/10.1681\/ASN.2017060659 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1127_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s13679-022-00473-1","volume":"11","author":"AI Legaki","year":"2022","unstructured":"Legaki, A. I. et al. Hepatocyte mitochondrial dynamics and bioenergetics in obesity-related non-alcoholic fatty liver disease. Curr. Obes. Rep. 11, 126\u2013143 https:\/\/doi.org\/10.1007\/s13679-022-00473-1 (2022).","journal-title":"Curr. Obes. Rep."},{"key":"1127_CR49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","volume":"1","author":"Z Arany","year":"2005","unstructured":"Arany, Z. et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 1, 259\u2013271 https:\/\/doi.org\/10.1016\/j.cmet.2005.03.002 (2005).","journal-title":"Cell Metab."},{"key":"1127_CR50","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.kint.2020.09.037","volume":"99","author":"AJ Clark","year":"2021","unstructured":"Clark, A. J. & Parikh, S. M. Targeting energy pathways in kidney disease: the roles of sirtuins, AMPK, and PGC1alpha. Kidney Int. 99, 828\u2013840 https:\/\/doi.org\/10.1016\/j.kint.2020.09.037 (2021).","journal-title":"Kidney Int."},{"key":"1127_CR51","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature07206","volume":"454","author":"C Handschin","year":"2008","unstructured":"Handschin, C. & Spiegelman, B. M. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454, 463\u2013469 https:\/\/doi.org\/10.1038\/nature07206 (2008).","journal-title":"Nature"},{"key":"1127_CR52","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature17184","volume":"531","author":"MT Tran","year":"2016","unstructured":"Tran, M. T. et al. PGC1alpha drives NAD biosynthesis linking oxidative metabolism to renal protection. Nature 531, 528\u2013532 https:\/\/doi.org\/10.1038\/nature17184 (2016).","journal-title":"Nature"},{"key":"1127_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121\u2013135 https:\/\/doi.org\/10.1038\/nrm.2017.95 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1127_CR54","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41586-019-1667-4","volume":"575","author":"A Hoshino","year":"2019","unstructured":"Hoshino, A. et al. The ADP\/ATP translocase drives mitophagy independent of nucleotide exchange. Nature 575, 375\u2013379 https:\/\/doi.org\/10.1038\/s41586-019-1667-4 (2019).","journal-title":"Nature"},{"key":"1127_CR55","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1074\/jbc.TM117.000893","volume":"294","author":"EA Moehle","year":"2019","unstructured":"Moehle, E. A., Shen, K. & Dillin, A. Mitochondrial proteostasis in the context of cellular and organismal health and aging. J. Biol. Chem. 294, 5396\u20135407 https:\/\/doi.org\/10.1074\/jbc.TM117.000893 (2019).","journal-title":"J. Biol. Chem."},{"key":"1127_CR56","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West, A. P. et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520, 553\u2013557 https:\/\/doi.org\/10.1038\/nature14156 (2015).","journal-title":"Nature"},{"key":"1127_CR57","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1172\/JCI61398","volume":"123","author":"DC Wallace","year":"2013","unstructured":"Wallace, D. C. A mitochondrial bioenergetic etiology of disease. J. Clin. Invest. 123, 1405\u20131412 https:\/\/doi.org\/10.1172\/JCI61398 (2013).","journal-title":"J. Clin. Invest."},{"key":"1127_CR58","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","volume":"30","author":"KW Chung","year":"2019","unstructured":"Chung, K. W. et al. Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis. Cell Metab. 30, 784\u2013799\u00a0https:\/\/doi.org\/10.1016\/j.cmet.2019.08.003 (2019).","journal-title":"Cell Metab."},{"key":"1127_CR59","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nri.2017.21","volume":"17","author":"AP West","year":"2017","unstructured":"West, A. P. & Shadel, G. S. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat. Rev. Immunol. 17, 363\u2013375 https:\/\/doi.org\/10.1038\/nri.2017.21 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"1127_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature10992","volume":"485","author":"T Oka","year":"2012","unstructured":"Oka, T. et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485, 251\u2013255 https:\/\/doi.org\/10.1038\/nature10992 (2012).","journal-title":"Nature"},{"key":"1127_CR61","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s42255-023-00761-7","volume":"5","author":"T Doke","year":"2023","unstructured":"Doke, T. et al. NAD(+) precursor supplementation prevents mtRNA\/RIG-I-dependent inflammation during kidney injury. Nat. Metab. 5, 414\u2013430 https:\/\/doi.org\/10.1038\/s42255-023-00761-7 (2023).","journal-title":"Nat. Metab."},{"key":"1127_CR62","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41581-025-00989-4","volume":"21","author":"YA Hong","year":"2025","unstructured":"Hong, Y. A. & Inagi, R. Endoplasmic reticulum-mediated organelle crosstalk in kidney disease. Nat. Rev. Nephrol. 21, 736\u2013755 https:\/\/doi.org\/10.1038\/s41581-025-00989-4 (2025).","journal-title":"Nat. Rev. Nephrol."},{"key":"1127_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cells13070609","volume":"13","author":"JM Fuentes","year":"2024","unstructured":"Fuentes, J. M. & Morcillo, P. The role of cardiolipin in mitochondrial function and neurodegenerative diseases. Cells 13, 609 https:\/\/doi.org\/10.3390\/cells13070609 (2024).","journal-title":"Cells"},{"key":"1127_CR64","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ceb.2020.01.006","volume":"63","author":"K Funai","year":"2020","unstructured":"Funai, K., Summers, S. A. & Rutter, J. Reign in the membrane: how common lipids govern mitochondrial function. Curr. Opin. Cell Biol. 63, 162\u2013173 https:\/\/doi.org\/10.1016\/j.ceb.2020.01.006 (2020).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1127_CR65","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.cmet.2024.07.024","volume":"36","author":"ST Decker","year":"2024","unstructured":"Decker, S. T. & Funai, K. Mitochondrial membrane lipids in the regulation of bioenergetic flux. Cell Metab. 36, 1963\u20131978 https:\/\/doi.org\/10.1016\/j.cmet.2024.07.024 (2024).","journal-title":"Cell Metab."},{"key":"1127_CR66","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41580-025-00854-z","volume":"26","author":"O Daumke","year":"2025","unstructured":"Daumke, O. & van der Laan, M. Molecular machineries shaping the mitochondrial inner membrane. Nat. Rev. Mol. Cell Biol. 26, 706\u2013724 https:\/\/doi.org\/10.1038\/s41580-025-00854-z (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1127_CR67","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.cmet.2021.07.008","volume":"33","author":"AG Gomez-Valades","year":"2021","unstructured":"Gomez-Valades, A. G. et al. Mitochondrial cristae-remodeling protein OPA1 in POMC neurons couples Ca2+ homeostasis with adipose tissue lipolysis. Cell Metab. 33, 1820\u20131835 https:\/\/doi.org\/10.1016\/j.cmet.2021.07.008 (2021).","journal-title":"Cell Metab."},{"key":"1127_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05070-6","volume":"81","author":"C Zhang","year":"2024","unstructured":"Zhang, C., Meng, Y. & Han, J. Emerging roles of mitochondrial functions and epigenetic changes in the modulation of stem cell fate. Cell Mol. Life Sci. 81, 26 https:\/\/doi.org\/10.1007\/s00018-023-05070-6 (2024).","journal-title":"Cell Mol. Life Sci."},{"key":"1127_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1393232","volume":"15","author":"M Laird","year":"2024","unstructured":"Laird, M. et al. Mitochondrial metabolism regulation and epigenetics in hypoxia. Front. Physiol. 15, 1393232 https:\/\/doi.org\/10.3389\/fphys.2024.1393232 (2024).","journal-title":"Front. Physiol."},{"key":"1127_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00605-5","volume":"11","author":"M Tajes","year":"2021","unstructured":"Tajes, M. et al. Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells. Cell Biosci. 11, 89 https:\/\/doi.org\/10.1186\/s13578-021-00605-5 (2021).","journal-title":"Cell Biosci."},{"key":"1127_CR71","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/CIRCHEARTFAILURE.112.966705","volume":"5","author":"J Mori","year":"2012","unstructured":"Mori, J. et al. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction. Circ. Heart Fail. 5, 493\u2013503 https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.966705 (2012).","journal-title":"Circ. Heart Fail."},{"key":"1127_CR72","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","volume":"108","author":"DF Dai","year":"2011","unstructured":"Dai, D. F. et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ. Res. 108, 837\u2013846 https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.232306 (2011).","journal-title":"Circ. Res."},{"key":"1127_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081682","volume":"18","author":"J Kaur","year":"2017","unstructured":"Kaur, J., Young, B. E. & Fadel, P. J. Sympathetic overactivity in chronic kidney disease: consequences and mechanisms. Int. J. Mol. Sci. 18, 1682 https:\/\/doi.org\/10.3390\/ijms18081682 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"1127_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115403","volume":"44","author":"J Xu","year":"2025","unstructured":"Xu, J. et al. The pro-inflammatory cytokine IL6 suppresses mitochondrial function via the gp130-JAK1\/STAT1\/3-HIF1alpha\/ERRalpha axis. Cell Rep. 44, 115403 https:\/\/doi.org\/10.1016\/j.celrep.2025.115403 (2025).","journal-title":"Cell Rep."},{"key":"1127_CR75","doi-asserted-by":"publisher","first-page":"E1033","DOI":"10.1152\/ajpendo.00422.2013","volume":"306","author":"WS Hahn","year":"2014","unstructured":"Hahn, W. S. et al. Proinflammatory cytokines differentially regulate adipocyte mitochondrial metabolism, oxidative stress, and dynamics. Am. J. Physiol. Endocrinol. Metab. 306, E1033\u2013E1045 https:\/\/doi.org\/10.1152\/ajpendo.00422.2013 (2014).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1127_CR76","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/ndt\/gfae193","volume":"40","author":"B Quiroga","year":"2025","unstructured":"Quiroga, B. & Diez, J. The kidney-skeletal muscle-heart axis in chronic kidney disease: implications for myokines. Nephrol. Dial. Transpl. 40, 255\u2013263 https:\/\/doi.org\/10.1093\/ndt\/gfae193 (2025).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1127_CR77","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","volume":"51","author":"DE Kelley","year":"2002","unstructured":"Kelley, D. E., He, J., Menshikova, E. V. & Ritov, V. B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944\u20132950 https:\/\/doi.org\/10.2337\/diabetes.51.10.2944 (2002).","journal-title":"Diabetes"},{"key":"1127_CR78","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2337\/diabetes.54.1.8","volume":"54","author":"VB Ritov","year":"2005","unstructured":"Ritov, V. B. et al. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54, 8\u201314 https:\/\/doi.org\/10.2337\/diabetes.54.1.8 (2005).","journal-title":"Diabetes"},{"key":"1127_CR79","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMoa031314","volume":"350","author":"KF Petersen","year":"2004","unstructured":"Petersen, K. F., Dufour, S., Befroy, D., Garcia, R. & Shulman, G. I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350, 664\u2013671 https:\/\/doi.org\/10.1056\/NEJMoa031314 (2004).","journal-title":"N. Engl. J. Med."},{"key":"1127_CR80","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/eurheartj\/ehad028","volume":"44","author":"EE Nollet","year":"2023","unstructured":"Nollet, E. E. et al. Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration. Eur. Heart J. 44, 1170\u20131185 https:\/\/doi.org\/10.1093\/eurheartj\/ehad028 (2023).","journal-title":"Eur. Heart J."},{"key":"1127_CR81","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.2337\/db07-1556","volume":"57","author":"KS Nair","year":"2008","unstructured":"Nair, K. S. et al. Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 57, 1166\u20131175 https:\/\/doi.org\/10.2337\/db07-1556 (2008).","journal-title":"Diabetes"},{"key":"1127_CR82","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.2337\/db05-1230","volume":"55","author":"YW Asmann","year":"2006","unstructured":"Asmann, Y. W. et al. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 55, 3309\u20133319 https:\/\/doi.org\/10.2337\/db05-1230 (2006).","journal-title":"Diabetes"},{"key":"1127_CR83","doi-asserted-by":"publisher","first-page":"E291","DOI":"10.1152\/ajpendo.00143.2023","volume":"325","author":"KL Whytock","year":"2023","unstructured":"Whytock, K. L. et al. Comprehensive interrogation of human skeletal muscle reveals a dissociation between insulin resistance and mitochondrial capacity. Am. J. Physiol. Endocrinol. Metab. 325, E291\u2013E302 https:\/\/doi.org\/10.1152\/ajpendo.00143.2023 (2023).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1127_CR84","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1172\/JCI25151","volume":"115","author":"K Morino","year":"2005","unstructured":"Morino, K. et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115, 3587\u20133593 https:\/\/doi.org\/10.1172\/JCI25151 (2005).","journal-title":"J. Clin. Invest."},{"key":"1127_CR85","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq4461","volume":"10","author":"M Fiorenza","year":"2024","unstructured":"Fiorenza, M. et al. Reducing the mitochondrial oxidative burden alleviates lipid-induced muscle insulin resistance in humans. Sci. Adv. 10, eadq4461 https:\/\/doi.org\/10.1126\/sciadv.adq4461 (2024).","journal-title":"Sci. Adv."},{"key":"1127_CR86","doi-asserted-by":"publisher","DOI":"10.1172\/JCI183567","volume":"135","author":"K Kido","year":"2025","unstructured":"Kido, K. et al. Intermittent ischemia\/reperfusion as a potent insulin-sensitizing intervention via blood flow enhancement and muscle decanoyl-l-carnitine suppression. J. Clin. Invest. 135, e183567 https:\/\/doi.org\/10.1172\/JCI183567 (2025).","journal-title":"J. Clin. Invest."},{"key":"1127_CR87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","volume":"7","author":"TR Koves","year":"2008","unstructured":"Koves, T. R. et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7, 45\u201356 https:\/\/doi.org\/10.1016\/j.cmet.2007.10.013 (2008).","journal-title":"Cell Metab."},{"key":"1127_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.106007","volume":"122","author":"E Zweck","year":"2025","unstructured":"Zweck, E. et al. Impaired mitochondrial ketone body oxidation in insulin resistant states. EBioMedicine 122, 106007 https:\/\/doi.org\/10.1016\/j.ebiom.2025.106007 (2025).","journal-title":"EBioMedicine"},{"key":"1127_CR89","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel, V. T. & Shulman, G. I. Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852\u2013871 https:\/\/doi.org\/10.1016\/j.cell.2012.02.017 (2012).","journal-title":"Cell"},{"key":"1127_CR90","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMra1011035","volume":"371","author":"GI Shulman","year":"2014","unstructured":"Shulman, G. I. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N. Engl. J. Med. 371, 1131\u20131141 https:\/\/doi.org\/10.1056\/NEJMra1011035 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1127_CR91","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","volume":"41","author":"MCK Severinsen","year":"2020","unstructured":"Severinsen, M. C. K. & Pedersen, B. K. Muscle-organ crosstalk: the emerging roles of myokines. Endocr. Rev. 41, 594\u2013609 https:\/\/doi.org\/10.1210\/endrev\/bnaa016 (2020).","journal-title":"Endocr. Rev."},{"key":"1127_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051290","volume":"11","author":"VJ Clemente-Suarez","year":"2023","unstructured":"Clemente-Suarez, V. J. et al. The role of adipokines in health and disease. Biomedicines 11, 1290 https:\/\/doi.org\/10.3390\/biomedicines11051290 (2023).","journal-title":"Biomedicines"},{"key":"1127_CR93","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41586-022-04518-2","volume":"603","author":"MP Emont","year":"2022","unstructured":"Emont, M. P. et al. A single-cell atlas of human and mouse white adipose tissue. Nature 603, 926\u2013933 https:\/\/doi.org\/10.1038\/s41586-022-04518-2 (2022).","journal-title":"Nature"},{"key":"1127_CR94","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41574-021-00471-8","volume":"17","author":"P Morigny","year":"2021","unstructured":"Morigny, P., Boucher, J., Arner, P. & Langin, D. Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics. Nat. Rev. Endocrinol. 17, 276\u2013295 https:\/\/doi.org\/10.1038\/s41574-021-00471-8 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1127_CR95","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","volume":"46","author":"S Cinti","year":"2005","unstructured":"Cinti, S. et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347\u20132355 https:\/\/doi.org\/10.1194\/jlr.M500294-JLR200 (2005).","journal-title":"J. Lipid Res."},{"key":"1127_CR96","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2021.12.016","volume":"185","author":"A Sakers","year":"2022","unstructured":"Sakers, A., De Siqueira, M. K., Seale, P. & Villanueva, C. J. Adipose-tissue plasticity in health and disease. Cell 185, 419\u2013446 https:\/\/doi.org\/10.1016\/j.cell.2021.12.016 (2022).","journal-title":"Cell"},{"key":"1127_CR97","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s42255-024-00978-0","volume":"6","author":"W Xia","year":"2024","unstructured":"Xia, W. et al. Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation. Nat. Metab. 6, 273\u2013289 https:\/\/doi.org\/10.1038\/s42255-024-00978-0 (2024).","journal-title":"Nat. Metab."},{"key":"1127_CR98","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.2337\/db14-1937","volume":"64","author":"S Heinonen","year":"2015","unstructured":"Heinonen, S. et al. Impaired mitochondrial biogenesis in adipose tissue in acquired obesity. Diabetes 64, 3135\u20133145 https:\/\/doi.org\/10.2337\/db14-1937 (2015).","journal-title":"Diabetes"},{"key":"1127_CR99","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/ng.3738","volume":"49","author":"AY Chu","year":"2017","unstructured":"Chu, A. Y. et al. Multiethnic genome-wide meta-analysis of ectopic fat depots identifies loci associated with adipocyte development and differentiation. Nat. Genet. 49, 125\u2013130 https:\/\/doi.org\/10.1038\/ng.3738 (2017).","journal-title":"Nat. Genet."},{"key":"1127_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413238","volume":"25","author":"J Janssen","year":"2024","unstructured":"Janssen, J. The causal role of ectopic fat deposition in the pathogenesis of metabolic syndrome. Int. J. Mol. Sci. 25, 13238 https:\/\/doi.org\/10.3390\/ijms252413238 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1127_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136848","author":"ICM Simoes","year":"2021","unstructured":"Simoes, I. C. M. et al. The alterations of mitochondrial function during NAFLD progression-an independent effect of mitochondrial ROS production. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22136848 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1127_CR102","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1136\/gutjnl-2020-321774","volume":"70","author":"N Sun","year":"2021","unstructured":"Sun, N. et al. Hepatic kruppel-like factor 16 (KLF16) targets PPARalpha to improve steatohepatitis and insulin resistance. Gut 70, 2183\u20132195 https:\/\/doi.org\/10.1136\/gutjnl-2020-321774 (2021).","journal-title":"Gut"},{"key":"1127_CR103","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jhep.2024.08.012","volume":"82","author":"S Kahl","year":"2025","unstructured":"Kahl, S. et al. Dysglycemia and liver lipid content determine the relationship of insulin resistance with hepatic OXPHOS capacity in obesity. J. Hepatol. 82, 417\u2013426 https:\/\/doi.org\/10.1016\/j.jhep.2024.08.012 (2025).","journal-title":"J. Hepatol."},{"key":"1127_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48272-7","volume":"15","author":"G Parlakgul","year":"2024","unstructured":"Parlakgul, G. et al. Spatial mapping of hepatic ER and mitochondria architecture reveals zonated remodeling in fasting and obesity. Nat. Commun. 15, 3982 https:\/\/doi.org\/10.1038\/s41467-024-48272-7 (2024).","journal-title":"Nat. Commun."},{"key":"1127_CR105","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/nu5041218","volume":"5","author":"B Klop","year":"2013","unstructured":"Klop, B., Elte, J. W. & Cabezas, M. C. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 5, 1218\u20131240 https:\/\/doi.org\/10.3390\/nu5041218 (2013).","journal-title":"Nutrients"},{"key":"1127_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102264","volume":"12","author":"S Shi","year":"2024","unstructured":"Shi, S. et al. The causal relationship between inflammatory cytokines and liver cirrhosis in European descent: a bidirectional two-sample Mendelian randomization study and the first conclusions. Biomedicines 12, 2264 https:\/\/doi.org\/10.3390\/biomedicines12102264 (2024).","journal-title":"Biomedicines"},{"key":"1127_CR107","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.122.062874","volume":"147","author":"F Capone","year":"2023","unstructured":"Capone, F., Vettor, R. & Schiattarella, G. G. Cardiometabolic HFpEF: NASH of the heart. Circulation 147, 451\u2013453 https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062874 (2023).","journal-title":"Circulation"},{"key":"1127_CR108","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","volume":"35","author":"N Stefan","year":"2023","unstructured":"Stefan, N., Schick, F., Birkenfeld, A. L., Haring, H. U. & White, M. F. The role of hepatokines in NAFLD. Cell Metab. 35, 236\u2013252 https:\/\/doi.org\/10.1016\/j.cmet.2023.01.006 (2023).","journal-title":"Cell Metab."},{"key":"1127_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4093\/dmj.2023.0115","volume":"48","author":"B Zhang","year":"2024","unstructured":"Zhang, B. et al. Mitochondrial stress and mitokines: therapeutic perspectives for the treatment of metabolic diseases. Diabetes Metab. J. 48, 1\u201318 https:\/\/doi.org\/10.4093\/dmj.2023.0115 (2024).","journal-title":"Diabetes Metab. J."},{"key":"1127_CR110","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","volume":"16","author":"L Geng","year":"2020","unstructured":"Geng, L., Lam, K. S. L. & Xu, A. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat. Rev. Endocrinol. 16, 654\u2013667 https:\/\/doi.org\/10.1038\/s41574-020-0386-0 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1127_CR111","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer, S. The failing heart\u2014an engine out of fuel. N. Engl. J. Med. 356, 1140\u20131151 https:\/\/doi.org\/10.1056\/NEJMra063052 (2007).","journal-title":"N. Engl. J. Med."},{"key":"1127_CR112","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.cmet.2024.06.003","volume":"36","author":"MR Bornstein","year":"2024","unstructured":"Bornstein, M. R., Tian, R. & Arany, Z. Human cardiac metabolism. Cell Metab. 36, 1456\u20131481 https:\/\/doi.org\/10.1016\/j.cmet.2024.06.003 (2024).","journal-title":"Cell Metab."},{"key":"1127_CR113","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000318227","volume":"116","author":"JC Fink","year":"2010","unstructured":"Fink, J. C. et al. Pre-clinical myocardial metabolic alterations in chronic kidney disease. Cardiology 116, 160\u2013167 https:\/\/doi.org\/10.1159\/000318227 (2010).","journal-title":"Cardiology"},{"key":"1127_CR114","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1161\/hc4901.100526","volume":"104","author":"P Razeghi","year":"2001","unstructured":"Razeghi, P. et al. Metabolic gene expression in fetal and failing human heart. Circulation 104, 2923\u20132931 https:\/\/doi.org\/10.1161\/hc4901.100526 (2001).","journal-title":"Circulation"},{"key":"1127_CR115","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10741-007-9034-1","volume":"12","author":"M Rajabi","year":"2007","unstructured":"Rajabi, M., Kassiotis, C., Razeghi, P. & Taegtmeyer, H. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail. Rev. 12, 331\u2013343 https:\/\/doi.org\/10.1007\/s10741-007-9034-1 (2007).","journal-title":"Heart Fail. Rev."},{"key":"1127_CR116","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0022-3565(25)10243-7","volume":"264","author":"GD Lopaschuk","year":"1993","unstructured":"Lopaschuk, G. D., Wambolt, R. B. & Barr, R. L. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J. Pharmacol. Exp. Ther. 264, 135\u2013144 (1993).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1127_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00068","volume":"5","author":"QG Karwi","year":"2018","unstructured":"Karwi, Q. G., Uddin, G. M., Ho, K. L. & Lopaschuk, G. D. Loss of metabolic flexibility in the failing heart. Front. Cardiovasc. Med. 5, 68 https:\/\/doi.org\/10.3389\/fcvm.2018.00068 (2018).","journal-title":"Front. Cardiovasc. Med."},{"key":"1127_CR118","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.2337\/db19-1057","volume":"69","author":"AR Wende","year":"2020","unstructured":"Wende, A. R. et al. Maintaining myocardial glucose utilization in diabetic cardiomyopathy accelerates mitochondrial dysfunction. Diabetes 69, 2094\u20132111 https:\/\/doi.org\/10.2337\/db19-1057 (2020).","journal-title":"Diabetes"},{"key":"1127_CR119","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/cvr\/cvab188","volume":"118","author":"N Naumenko","year":"2022","unstructured":"Naumenko, N. et al. PGC-1alpha deficiency reveals sex-specific links between cardiac energy metabolism and EC-coupling during development of heart failure in mice. Cardiovasc. Res. 118, 1520\u20131534 https:\/\/doi.org\/10.1093\/cvr\/cvab188 (2022).","journal-title":"Cardiovasc. Res."},{"key":"1127_CR120","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1172\/JCI27794","volume":"116","author":"BN Finck","year":"2006","unstructured":"Finck, B. N. & Kelly, D. P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116, 615\u2013622 https:\/\/doi.org\/10.1172\/JCI27794 (2006).","journal-title":"J. Clin. Invest."},{"key":"1127_CR121","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ejhf.1320","volume":"21","author":"A van der Pol","year":"2019","unstructured":"van der Pol, A., van Gilst, W. H., Voors, A. A. & van der Meer, P. Treating oxidative stress in heart failure: past, present and future. Eur. J. Heart Fail. 21, 425\u2013435 https:\/\/doi.org\/10.1002\/ejhf.1320 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"1127_CR122","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1089\/ars.2024.0706","volume":"42","author":"SM Craige","year":"2025","unstructured":"Craige, S. M. et al. Endothelial reactive oxygen species: key players in cardiovascular health and disease. Antioxid. Redox Signal. 42, 905\u2013932 https:\/\/doi.org\/10.1089\/ars.2024.0706 (2025).","journal-title":"Antioxid. Redox Signal."},{"key":"1127_CR123","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.freeradbiomed.2011.05.004","volume":"51","author":"K Sugamura","year":"2011","unstructured":"Sugamura, K. & Keaney, J. F. Jr. Reactive oxygen species in cardiovascular disease. Free. Radic. Biol. Med. 51, 978\u2013992 https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.05.004 (2011).","journal-title":"Free. Radic. Biol. Med."},{"key":"1127_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015472","author":"AA Manolis","year":"2023","unstructured":"Manolis, A. A., Manolis, T. A. & Manolis, A. S. Neurohumoral activation in heart failure. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms242015472 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1127_CR125","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1161\/CIRCULATIONAHA.118.039329","volume":"139","author":"GL Smith","year":"2019","unstructured":"Smith, G. L. & Eisner, D. A. Calcium buffering in the heart in health and disease. Circulation 139, 2358\u20132371 https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.039329 (2019).","journal-title":"Circulation"},{"key":"1127_CR126","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/CIRCRESAHA.119.316306","volume":"126","author":"TM Bauer","year":"2020","unstructured":"Bauer, T. M. & Murphy, E. Role of mitochondrial calcium and the permeability transition pore in regulating cell death. Circ. Res. 126, 280\u2013293 https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.316306 (2020).","journal-title":"Circ. Res."},{"key":"1127_CR127","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/cvr\/cvac134","volume":"119","author":"E Murphy","year":"2023","unstructured":"Murphy, E. & Liu, J. C. Mitochondrial calcium and reactive oxygen species in cardiovascular disease. Cardiovasc. Res. 119, 1105\u20131116 https:\/\/doi.org\/10.1093\/cvr\/cvac134 (2023).","journal-title":"Cardiovasc. Res."},{"key":"1127_CR128","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang, X., Ardehali, H., Min, J. & Wang, F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat. Rev. Cardiol. 20, 7\u201323 https:\/\/doi.org\/10.1038\/s41569-022-00735-4 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"1127_CR129","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad2459","volume":"350","author":"G Gong","year":"2015","unstructured":"Gong, G. et al. Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice. Science 350, aad2459 https:\/\/doi.org\/10.1126\/science.aad2459 (2015).","journal-title":"Science"},{"key":"1127_CR130","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cmet.2014.12.019","volume":"21","author":"M Song","year":"2015","unstructured":"Song, M. & Dorn, G. W. 2nd. Mitoconfusion: noncanonical functioning of dynamism factors in static mitochondria of the heart. Cell Metab. 21, 195\u2013205 https:\/\/doi.org\/10.1016\/j.cmet.2014.12.019 (2015).","journal-title":"Cell Metab."},{"key":"1127_CR131","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvag006","author":"Y Kondo","year":"2026","unstructured":"Kondo, Y. et al. Drp1-mediated mitochondrial fission protects macrophages from mtDNA\/ZBP1-mediated inflammation and inhibits post-infarct cardiac remodeling. Cardiovasc. Res. https:\/\/doi.org\/10.1093\/cvr\/cvag006 (2026).","journal-title":"Cardiovasc. Res."},{"key":"1127_CR132","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cmet.2014.12.011","volume":"21","author":"M Song","year":"2015","unstructured":"Song, M., Mihara, K., Chen, Y., Scorrano, L. & Dorn, G. W. 2nd. Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts. Cell Metab. 21, 273\u2013286 https:\/\/doi.org\/10.1016\/j.cmet.2014.12.011 (2015).","journal-title":"Cell Metab."},{"key":"1127_CR133","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00109-015-1254-6","volume":"93","author":"SE Shires","year":"2015","unstructured":"Shires, S. E. & Gustafsson, A. B. Mitophagy and heart failure. J. Mol. Med. 93, 253\u2013262 https:\/\/doi.org\/10.1007\/s00109-015-1254-6 (2015).","journal-title":"J. Mol. Med."},{"key":"1127_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00193","volume":"6","author":"A Arrieta","year":"2019","unstructured":"Arrieta, A., Blackwood, E. A., Stauffer, W. T. & Glembotski, C. C. Integrating ER and mitochondrial proteostasis in the healthy and diseased heart. Front. Cardiovasc. Med. 6, 193 https:\/\/doi.org\/10.3389\/fcvm.2019.00193 (2019).","journal-title":"Front. Cardiovasc. Med."},{"key":"1127_CR135","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.125.326929","volume":"138","author":"R Haddad","year":"2026","unstructured":"Haddad, R. et al. Subcellular in vivo cardiac proteomics reveals sarcomere and ribosome interactomes and skNAC\u2019s impact on cardiac proteostasis. Circ. Res. 138, e326929 https:\/\/doi.org\/10.1161\/CIRCRESAHA.125.326929 (2026).","journal-title":"Circ. Res."},{"key":"1127_CR136","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jacbts.2020.05.007","volume":"5","author":"J Zhao","year":"2020","unstructured":"Zhao, J. & Pei, L. Cardiac endocrinology: heart-derived hormones in physiology and disease. JACC Basic. Transl. Sci. 5, 949\u2013960 https:\/\/doi.org\/10.1016\/j.jacbts.2020.05.007 (2020).","journal-title":"JACC Basic. Transl. Sci."},{"key":"1127_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-025-01234-y","author":"NC Edwards","year":"2026","unstructured":"Edwards, N. C., Pavlovic, D., Ferro, C. J. & Townend, J. N. Chronic kidney disease-associated cardiomyopathy: clinical features, pathophysiology and treatment. Nat. Rev. Cardiol. https:\/\/doi.org\/10.1038\/s41569-025-01234-y (2026).","journal-title":"Nat. Rev. Cardiol."},{"key":"1127_CR138","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/CIRCRESAHA.124.325488","volume":"136","author":"H Noels","year":"2025","unstructured":"Noels, H. et al. Renal-cardiac crosstalk in the pathogenesis and progression of heart failure. Circ. Res. 136, 1306\u20131334 https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.325488 (2025).","journal-title":"Circ. Res."},{"key":"1127_CR139","doi-asserted-by":"publisher","DOI":"10.1113\/JP287400","author":"MG Sen","year":"2025","unstructured":"Sen, M. G., Chooi, R. & McMullen, J. R. Heart-derived factors and organ cross-talk in settings of health and disease: new knowledge and clinical opportunities for multimorbidity. J. Physiol. https:\/\/doi.org\/10.1113\/JP287400 (2025).","journal-title":"J. Physiol."},{"key":"1127_CR140","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1161\/CIRCULATIONAHA.112.150656","volume":"126","author":"M Shimano","year":"2012","unstructured":"Shimano, M., Ouchi, N. & Walsh, K. Cardiokines: recent progress in elucidating the cardiac secretome. Circulation 126, e327\u2013e332 https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.150656 (2012).","journal-title":"Circulation"},{"key":"1127_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1012403","volume":"9","author":"K Sundquist","year":"2022","unstructured":"Sundquist, K., Sundquist, J., Wang, X., Palmer, K. & Memon, A. A. Baseline mitochondrial DNA copy number and heart failure incidence and its role in overall and heart failure mortality in middle-aged women. Front. Cardiovasc. Med. 9, 1012403 https:\/\/doi.org\/10.3389\/fcvm.2022.1012403 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1127_CR142","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029090","volume":"12","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Association between whole blood-derived mitochondrial DNA copy number, low-density lipoprotein cholesterol, and cardiovascular disease risk. J. Am. Heart Assoc. 12, e029090 https:\/\/doi.org\/10.1161\/JAHA.122.029090 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"1127_CR143","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/jamacardio.2017.3683","volume":"2","author":"FN Ashar","year":"2017","unstructured":"Ashar, F. N. et al. Association of mitochondrial DNA copy number with cardiovascular disease. JAMA Cardiol. 2, 1247\u20131255 https:\/\/doi.org\/10.1001\/jamacardio.2017.3683 (2017).","journal-title":"JAMA Cardiol."},{"key":"1127_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.endmts.2025.100288","volume":"20","author":"MS Ali","year":"2026","unstructured":"Ali, M. S., Islam, M. J., Ebihara, A. & Nabi, A. H. M. N. Mitochondrial DNA variants, copy number and haplogroups in type 2 diabetes: a systematic review and meta-analysis in different ethnic population. Endocr. Metab. Sci. 20, 100288 https:\/\/doi.org\/10.1016\/j.endmts.2025.100288 (2026).","journal-title":"Endocr. Metab. Sci."},{"key":"1127_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052973","author":"G Gallo","year":"2024","unstructured":"Gallo, G. & Savoia, C. New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms25052973 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1127_CR146","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cmet.2020.05.018","volume":"32","author":"A Ibrahim","year":"2020","unstructured":"Ibrahim, A., Yucel, N., Kim, B. & Arany, Z. Local mitochondrial ATP production regulates endothelial fatty acid uptake and transport. Cell Metab. 32, 309\u2013319\u00a0https:\/\/doi.org\/10.1016\/j.cmet.2020.05.018 (2020).","journal-title":"Cell Metab."},{"key":"1127_CR147","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/CIRCRESAHA.121.318982","volume":"129","author":"SE Basehore","year":"2021","unstructured":"Basehore, S. E. et al. Laminar flow on endothelial cells suppresses eNOS O-GlcNAcylation to promote eNOS activity. Circ. Res. 129, 1054\u20131066 https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318982 (2021).","journal-title":"Circ. Res."},{"key":"1127_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2544-7","volume":"11","author":"T Cai","year":"2020","unstructured":"Cai, T. et al. Sodium-glucose cotransporter 2 inhibition suppresses HIF-1alpha-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice. Cell Death Dis. 11, 390 https:\/\/doi.org\/10.1038\/s41419-020-2544-7 (2020).","journal-title":"Cell Death Dis."},{"key":"1127_CR149","doi-asserted-by":"publisher","first-page":"355","DOI":"10.34067\/KID.0004772020","volume":"2","author":"JA Schaub","year":"2021","unstructured":"Schaub, J. A., Venkatachalam, M. A. & Weinberg, J. M. Proximal tubular oxidative metabolism in acute kidney injury and the transition to CKD. Kidney360 2, 355\u2013364 https:\/\/doi.org\/10.34067\/KID.0004772020 (2021).","journal-title":"Kidney360"},{"key":"1127_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106462","volume":"26","author":"M Darshi","year":"2023","unstructured":"Darshi, M. et al. Crabtree effect in kidney proximal tubule cells via late-stage glycolytic intermediates. iScience 26, 106462 https:\/\/doi.org\/10.1016\/j.isci.2023.106462 (2023).","journal-title":"iScience"},{"key":"1127_CR151","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040722","author":"Z Gai","year":"2019","unstructured":"Gai, Z. et al. Lipid accumulation and chronic kidney disease. Nutrients https:\/\/doi.org\/10.3390\/nu11040722 (2019).","journal-title":"Nutrients"},{"key":"1127_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04515-3","volume":"13","author":"J Li","year":"2022","unstructured":"Li, J. et al. STAT6 contributes to renal fibrosis by modulating PPARalpha-mediated tubular fatty acid oxidation. Cell Death Dis. 13, 66 https:\/\/doi.org\/10.1038\/s41419-022-04515-3 (2022).","journal-title":"Cell Death Dis."},{"key":"1127_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00065","volume":"7","author":"HS Jang","year":"2020","unstructured":"Jang, H. S., Noh, M. R., Kim, J. & Padanilam, B. J. Defective mitochondrial fatty acid oxidation and lipotoxicity in kidney diseases. Front. Med. 7, 65 https:\/\/doi.org\/10.3389\/fmed.2020.00065 (2020).","journal-title":"Front. Med."},{"key":"1127_CR154","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2426179122","volume":"122","author":"W Fan","year":"2025","unstructured":"Fan, W. et al. Estrogen-related receptors regulate innate and adaptive muscle mitochondrial energetics through cooperative and distinct actions. Proc. Natl Acad. Sci. USA 122, e2426179122 https:\/\/doi.org\/10.1073\/pnas.2426179122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1127_CR155","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1172\/JCI58662","volume":"121","author":"M Tran","year":"2011","unstructured":"Tran, M. et al. PGC-1alpha promotes recovery after acute kidney injury during systemic inflammation in mice. J. Clin. Invest. 121, 4003\u20134014 https:\/\/doi.org\/10.1172\/JCI58662 (2011).","journal-title":"J. Clin. Invest."},{"key":"1127_CR156","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1016\/j.ymthe.2023.08.014","volume":"31","author":"M Zhu","year":"2023","unstructured":"Zhu, M. et al. AMPK activation coupling SENP1-Sirt3 axis protects against acute kidney injury. Mol. Ther. 31, 3052\u20133066 https:\/\/doi.org\/10.1016\/j.ymthe.2023.08.014 (2023).","journal-title":"Mol. Ther."},{"key":"1127_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.627837","volume":"12","author":"H Tirichen","year":"2021","unstructured":"Tirichen, H. et al. Mitochondrial reactive oxygen species and their contribution in chronic kidney disease progression through oxidative stress. Front. Physiol. 12, 627837 https:\/\/doi.org\/10.3389\/fphys.2021.627837 (2021).","journal-title":"Front. Physiol."},{"key":"1127_CR158","doi-asserted-by":"publisher","first-page":"F683","DOI":"10.1152\/ajprenal.00417.2019","volume":"318","author":"M Friederich-Persson","year":"2020","unstructured":"Friederich-Persson, M. & Persson, P. Mitochondrial angiotensin II receptors regulate oxygen consumption in kidney mitochondria from healthy and type 1 diabetic rats. Am. J. Physiol. Ren. Physiol. 318, F683\u2013F688 https:\/\/doi.org\/10.1152\/ajprenal.00417.2019 (2020).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1127_CR159","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-025-00713-0","volume":"22","author":"E Long","year":"2025","unstructured":"Long, E. & Heihre, J. M. Recharging the powerhouse: mitochondrial dysfunction and therapy in cardiorenal syndrome type 4. Curr. Heart Fail. Rep. 22, 24 https:\/\/doi.org\/10.1007\/s11897-025-00713-0 (2025).","journal-title":"Curr. Heart Fail. Rep."},{"key":"1127_CR160","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/nar\/gkp100","volume":"37","author":"I Shokolenko","year":"2009","unstructured":"Shokolenko, I., Venediktova, N., Bochkareva, A., Wilson, G. L. & Alexeyev, M. F. Oxidative stress induces degradation of mitochondrial DNA. Nucleic Acids Res. 37, 2539\u20132548 https:\/\/doi.org\/10.1093\/nar\/gkp100 (2009).","journal-title":"Nucleic Acids Res."},{"key":"1127_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06247-4","volume":"14","author":"L Shi","year":"2023","unstructured":"Shi, L. et al. DUSP1 protects against ischemic acute kidney injury through stabilizing mtDNA via interaction with JNK. Cell Death Dis. 14, 724 https:\/\/doi.org\/10.1038\/s41419-023-06247-4 (2023).","journal-title":"Cell Death Dis."},{"key":"1127_CR162","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.celrep.2019.09.050","volume":"29","author":"H Maekawa","year":"2019","unstructured":"Maekawa, H. et al. Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury. Cell Rep. 29, 1261\u20131273\u00a0https:\/\/doi.org\/10.1016\/j.celrep.2019.09.050 (2019).","journal-title":"Cell Rep."},{"key":"1127_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105145","volume":"25","author":"N Zang","year":"2022","unstructured":"Zang, N. et al. cGAS-STING activation contributes to podocyte injury in diabetic kidney disease. iScience 25, 105145 https:\/\/doi.org\/10.1016\/j.isci.2022.105145 (2022).","journal-title":"iScience"},{"key":"1127_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06144-w","volume":"14","author":"J Li","year":"2023","unstructured":"Li, J., Zheng, S., Fan, Y. & Tan, K. Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases. Cell Death Dis. 14, 628 https:\/\/doi.org\/10.1038\/s41419-023-06144-w (2023).","journal-title":"Cell Death Dis."},{"key":"1127_CR165","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2024.10.007","volume":"37","author":"S Li","year":"2025","unstructured":"Li, S. et al. Human genetics identify convergent signals in mitochondrial LACTB-mediated lipid metabolism in cardiovascular-kidney-metabolic syndrome. Cell Metab. 37, 154\u2013168 https:\/\/doi.org\/10.1016\/j.cmet.2024.10.007 (2025).","journal-title":"Cell Metab."},{"key":"1127_CR166","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn3079","volume":"17","author":"LP Kolligundla","year":"2025","unstructured":"Kolligundla, L. P. et al. Glutathione-specific gamma-glutamylcyclotransferase 1 (CHAC1) increases kidney disease risk by modulating ferroptosis. Sci. Transl. Med. 17, eadn3079 https:\/\/doi.org\/10.1126\/scitranslmed.adn3079 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1127_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25377-x","volume":"12","author":"Y Guan","year":"2021","unstructured":"Guan, Y. et al. A single genetic locus controls both expression of DPEP1\/CHMP1A and kidney disease development via ferroptosis. Nat. Commun. 12, 5078 https:\/\/doi.org\/10.1038\/s41467-021-25377-x (2021).","journal-title":"Nat. Commun."},{"key":"1127_CR168","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2024.01.030","volume":"187","author":"B Qiu","year":"2024","unstructured":"Qiu, B. et al. Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis. Cell 187, 1177\u20131190\u00a0https:\/\/doi.org\/10.1016\/j.cell.2024.01.030 (2024).","journal-title":"Cell"},{"key":"1127_CR169","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00125-025-06612-2","volume":"69","author":"S Matsui","year":"2026","unstructured":"Matsui, S. et al. Defective autophagy and AMPK inactivation drive ferroptosis in diabetic kidney disease. Diabetologia 69, 815\u2013832 https:\/\/doi.org\/10.1007\/s00125-025-06612-2 (2026).","journal-title":"Diabetologia"},{"key":"1127_CR170","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.tcb.2022.03.012","volume":"32","author":"T Doke","year":"2022","unstructured":"Doke, T. & Susztak, K. The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development. Trends Cell Biol. 32, 841\u2013853 https:\/\/doi.org\/10.1016\/j.tcb.2022.03.012 (2022).","journal-title":"Trends Cell Biol."},{"key":"1127_CR171","doi-asserted-by":"publisher","unstructured":"Khan, M. A. et al. Mitochondrial organization in the developing proximal tubule is controlled by LRRK2. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.09.02.673829 (2025).","DOI":"10.1101\/2025.09.02.673829"},{"key":"1127_CR172","doi-asserted-by":"publisher","first-page":"F955","DOI":"10.1152\/ajprenal.00393.2020","volume":"319","author":"NA Gujarati","year":"2020","unstructured":"Gujarati, N. A., Vasquez, J. M., Bogenhagen, D. F. & Mallipattu, S. K. The complicated role of mitochondria in the podocyte. Am. J. Physiol. Ren. Physiol. 319, F955\u2013F965 https:\/\/doi.org\/10.1152\/ajprenal.00393.2020 (2020).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1127_CR173","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41581-024-00843-z","volume":"20","author":"K Meliambro","year":"2024","unstructured":"Meliambro, K., He, J. C. & Campbell, K. N. Podocyte-targeted therapies \u2014 progress and future directions. Nat. Rev. Nephrol. 20, 643\u2013658 https:\/\/doi.org\/10.1038\/s41581-024-00843-z (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"1127_CR174","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cmet.2012.01.009","volume":"15","author":"W Wang","year":"2012","unstructured":"Wang, W. et al. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab. 15, 186\u2013200 https:\/\/doi.org\/10.1016\/j.cmet.2012.01.009 (2012).","journal-title":"Cell Metab."},{"key":"1127_CR175","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2215\/CJN.09400913","volume":"9","author":"MR Pollak","year":"2014","unstructured":"Pollak, M. R., Quaggin, S. E., Hoenig, M. P. & Dworkin, L. D. The glomerulus: the sphere of influence. Clin. J. Am. Soc. Nephrol. 9, 1461\u20131469 https:\/\/doi.org\/10.2215\/CJN.09400913 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1127_CR176","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2337\/diabetes.55.01.06.db05-0894","volume":"55","author":"K Susztak","year":"2006","unstructured":"Susztak, K., Raff, A. C., Schiffer, M. & Bottinger, E. P. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55, 225\u2013233 (2006).","journal-title":"Diabetes"},{"key":"1127_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2218-5","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Drp1-mediated mitochondrial fission promotes renal fibroblast activation and fibrogenesis. Cell Death Dis. 11, 29 https:\/\/doi.org\/10.1038\/s41419-019-2218-5 (2020).","journal-title":"Cell Death Dis."},{"key":"1127_CR178","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","volume":"78","author":"FM Fisher","year":"2016","unstructured":"Fisher, F. M. & Maratos-Flier, E. Understanding the physiology of FGF21. Annu. Rev. Physiol. 78, 223\u2013241 https:\/\/doi.org\/10.1146\/annurev-physiol-021115-105339 (2016).","journal-title":"Annu. Rev. Physiol."},{"key":"1127_CR179","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.15252\/emmm.201707604","volume":"9","author":"T Wang","year":"2017","unstructured":"Wang, T. et al. GDF15 is a heart-derived hormone that regulates body growth. EMBO Mol. Med. 9, 1150\u20131164 https:\/\/doi.org\/10.15252\/emmm.201707604 (2017).","journal-title":"EMBO Mol. Med."},{"key":"1127_CR180","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s42255-019-0146-4","volume":"1","author":"EA Day","year":"2019","unstructured":"Day, E. A. et al. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss. Nat. Metab. 1, 1202\u20131208 https:\/\/doi.org\/10.1038\/s42255-019-0146-4 (2019).","journal-title":"Nat. Metab."},{"key":"1127_CR181","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s42255-021-00354-2","volume":"3","author":"KH Flippo","year":"2021","unstructured":"Flippo, K. H. & Potthoff, M. J. Metabolic messengers: FGF21. Nat. Metab. 3, 309\u2013317 https:\/\/doi.org\/10.1038\/s42255-021-00354-2 (2021).","journal-title":"Nat. Metab."},{"key":"1127_CR182","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s42255-021-00366-y","volume":"3","author":"JH Weng","year":"2021","unstructured":"Weng, J. H. et al. Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation. Nat. Metab. 3, 513\u2013522 https:\/\/doi.org\/10.1038\/s42255-021-00366-y (2021).","journal-title":"Nat. Metab."},{"key":"1127_CR183","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cmet.2023.03.014","volume":"35","author":"SY Zhang","year":"2023","unstructured":"Zhang, S. Y. et al. Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight. Cell Metab. 35, 875\u2013886\u00a0https:\/\/doi.org\/10.1016\/j.cmet.2023.03.014 (2023).","journal-title":"Cell Metab."},{"key":"1127_CR184","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"AP Coll","year":"2020","unstructured":"Coll, A. P. et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578, 444\u2013448 https:\/\/doi.org\/10.1038\/s41586-019-1911-y (2020).","journal-title":"Nature"},{"key":"1127_CR185","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cmet.2019.01.004","volume":"29","author":"SA Kliewer","year":"2019","unstructured":"Kliewer, S. A. & Mangelsdorf, D. J. A dozen years of discovery: insights into the physiology and pharmacology of FGF21. Cell Metab. 29, 246\u2013253 https:\/\/doi.org\/10.1016\/j.cmet.2019.01.004 (2019).","journal-title":"Cell Metab."},{"key":"1127_CR186","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s42255-025-01264-3","volume":"7","author":"LK Townsend","year":"2025","unstructured":"Townsend, L. K. et al. GDF15 links adipose tissue lipolysis with anxiety. Nat. Metab. 7, 1004\u20131017 https:\/\/doi.org\/10.1038\/s42255-025-01264-3 (2025).","journal-title":"Nat. Metab."},{"key":"1127_CR187","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42255-021-00389-5","volume":"3","author":"EL Mills","year":"2021","unstructured":"Mills, E. L. et al. UCP1 governs liver extracellular succinate and inflammatory pathogenesis. Nat. Metab. 3, 604\u2013617 https:\/\/doi.org\/10.1038\/s42255-021-00389-5 (2021).","journal-title":"Nat. Metab."},{"key":"1127_CR188","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2018.07.030","volume":"174","author":"MP Murphy","year":"2018","unstructured":"Murphy, M. P. & O\u2019Neill, L. A. J. Krebs cycle reimagined: the emerging roles of succinate and itaconate as signal transducers. Cell 174, 780\u2013784 https:\/\/doi.org\/10.1016\/j.cell.2018.07.030 (2018).","journal-title":"Cell"},{"key":"1127_CR189","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2020.08.039","volume":"183","author":"A Reddy","year":"2020","unstructured":"Reddy, A. et al. pH-gated succinate secretion regulates muscle remodeling in response to exercise. Cell 183, 62\u201375\u00a0https:\/\/doi.org\/10.1016\/j.cell.2020.08.039 (2020).","journal-title":"Cell"},{"key":"1127_CR190","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1152\/physrev.00008.2023","volume":"104","author":"JL Wilkerson","year":"2024","unstructured":"Wilkerson, J. L., Tatum, S. M., Holland, W. L. & Summers, S. A. Ceramides are fuel gauges on the drive to cardiometabolic disease. Physiol. Rev. 104, 1061\u20131119 https:\/\/doi.org\/10.1152\/physrev.00008.2023 (2024).","journal-title":"Physiol. Rev."},{"key":"1127_CR191","doi-asserted-by":"publisher","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","volume":"287","author":"MA Lanaspa","year":"2012","unstructured":"Lanaspa, M. A. et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J. Biol. Chem. 287, 40732\u201340744 https:\/\/doi.org\/10.1074\/jbc.M112.399899 (2012).","journal-title":"J. Biol. Chem."},{"key":"1127_CR192","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70163","volume":"9","author":"N Ali","year":"2026","unstructured":"Ali, N. Serum uric acid as a mediator of insulin resistance: molecular mechanisms and metabolic pathways. Endocrinol. Diabetes Metab. 9, e70163 https:\/\/doi.org\/10.1002\/edm2.70163 (2026).","journal-title":"Endocrinol. Diabetes Metab."},{"key":"1127_CR193","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","volume":"103","author":"S Copur","year":"2022","unstructured":"Copur, S., Demiray, A. & Kanbay, M. Uric acid in metabolic syndrome: does uric acid have a definitive role? Eur. J. Intern. Med. 103, 4\u201312 https:\/\/doi.org\/10.1016\/j.ejim.2022.04.022 (2022).","journal-title":"Eur. J. Intern. Med."},{"key":"1127_CR194","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1161\/CIRCRESAHA.123.321759","volume":"132","author":"TD Nguyen","year":"2023","unstructured":"Nguyen, T. D. & Schulze, P. C. Cardiac metabolism in heart failure and implications for uremic cardiomyopathy. Circ. Res. 132, 1034\u20131049 https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.321759 (2023).","journal-title":"Circ. Res."},{"key":"1127_CR195","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41581-018-0101-8","volume":"15","author":"X Wang","year":"2019","unstructured":"Wang, X. & Shapiro, J. I. Evolving concepts in the pathogenesis of uraemic cardiomyopathy. Nat. Rev. Nephrol. 15, 159\u2013175 https:\/\/doi.org\/10.1038\/s41581-018-0101-8 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"1127_CR196","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41581-019-0111-1","volume":"15","author":"SK Nigam","year":"2019","unstructured":"Nigam, S. K. & Bush, K. T. Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling. Nat. Rev. Nephrol. 15, 301\u2013316 https:\/\/doi.org\/10.1038\/s41581-019-0111-1 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"1127_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.686249","volume":"12","author":"CA Falconi","year":"2021","unstructured":"Falconi, C. A. et al. Uremic toxins: an alarming danger concerning the cardiovascular system. Front. Physiol. 12, 686249 https:\/\/doi.org\/10.3389\/fphys.2021.686249 (2021).","journal-title":"Front. Physiol."},{"key":"1127_CR198","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-023-06537-z","volume":"623","author":"N Borcherding","year":"2023","unstructured":"Borcherding, N. & Brestoff, J. R. The power and potential of mitochondria transfer. Nature 623, 283\u2013291 https:\/\/doi.org\/10.1038\/s41586-023-06537-z (2023).","journal-title":"Nature"},{"key":"1127_CR199","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.cmet.2021.08.002","volume":"33","author":"C Crewe","year":"2021","unstructured":"Crewe, C. et al. Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes. Cell Metab. 33, 1853\u20131868\u00a0https:\/\/doi.org\/10.1016\/j.cmet.2021.08.002 (2021).","journal-title":"Cell Metab."},{"key":"1127_CR200","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cell.2020.08.031","volume":"183","author":"JA Nicolas-Avila","year":"2020","unstructured":"Nicolas-Avila, J. A. et al. A network of macrophages supports mitochondrial homeostasis in the heart. Cell 183, 94\u2013109\u00a0https:\/\/doi.org\/10.1016\/j.cell.2020.08.031 (2020).","journal-title":"Cell"},{"key":"1127_CR201","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink, H. J. L. et al. Dapagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 383, 1436\u20131446 https:\/\/doi.org\/10.1056\/NEJMoa2024816 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1127_CR202","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1056\/NEJMra2115011","volume":"386","author":"E Braunwald","year":"2022","unstructured":"Braunwald, E. Gliflozins in the management of cardiovascular disease. N. Engl. J. Med. 386, 2024\u20132034 https:\/\/doi.org\/10.1056\/NEJMra2115011 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1127_CR203","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41581-022-00535-6","volume":"18","author":"AB van der Aart-van der Beek","year":"2022","unstructured":"van der Aart-van der Beek, A. B., de Boer, R. A. & Heerspink, H. J. L. Kidney and heart failure outcomes associated with SGLT2 inhibitor use. Nat. Rev. Nephrol. 18, 294\u2013306 https:\/\/doi.org\/10.1038\/s41581-022-00535-6 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1127_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154918","volume":"126","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease. Metabolism 126, 154918 https:\/\/doi.org\/10.1016\/j.metabol.2021.154918 (2022).","journal-title":"Metabolism"},{"key":"1127_CR205","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","volume":"17","author":"MR Cowie","year":"2020","unstructured":"Cowie, M. R. & Fisher, M. SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control. Nat. Rev. Cardiol. 17, 761\u2013772 https:\/\/doi.org\/10.1038\/s41569-020-0406-8 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"1127_CR206","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1126\/science.aeh4856","volume":"393","author":"N Forelli","year":"2026","unstructured":"Forelli, N. et al. SGLT2 inhibitors activate pantothenate kinase in the human heart. Science 393, 895\u2013902 https:\/\/doi.org\/10.1126\/science.aeh4856 (2026).","journal-title":"Science"},{"key":"1127_CR207","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","volume":"391","author":"V Perkovic","year":"2024","unstructured":"Perkovic, V. et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N. Engl. J. Med. 391, 109\u2013121 https:\/\/doi.org\/10.1056\/NEJMoa2403347 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1127_CR208","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1001\/jama.2025.0548","volume":"333","author":"S Anderer","year":"2025","unstructured":"Anderer, S. FDA approves semaglutide to reduce risk of kidney disease progression. JAMA 333, 1109\u20131109 https:\/\/doi.org\/10.1001\/jama.2025.0548 (2025).","journal-title":"JAMA"},{"key":"1127_CR209","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod, M. N. et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N. Engl. J. Med. 389, 1069\u20131084 https:\/\/doi.org\/10.1056\/NEJMoa2306963 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1127_CR210","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","volume":"391","author":"SD Solomon","year":"2024","unstructured":"Solomon, S. D. et al. Finerenone in heart failure with mildly reduced or preserved ejection fraction. N. Engl. J. Med. 391, 1475\u20131485 https:\/\/doi.org\/10.1056\/NEJMoa2407107 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1127_CR211","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/dom.14669","volume":"24","author":"SA Mason","year":"2022","unstructured":"Mason, S. A., Wadley, G. D., Keske, M. A. & Parker, L. Effect of mitochondrial-targeted antioxidants on glycaemic control, cardiovascular health, and oxidative stress in humans: a systematic review and meta-analysis of randomized controlled trials. Diabetes Obes. Metab. 24, 1047\u20131060 https:\/\/doi.org\/10.1111\/dom.14669 (2022).","journal-title":"Diabetes Obes. Metab."},{"key":"1127_CR212","doi-asserted-by":"publisher","first-page":"F448","DOI":"10.1152\/ajprenal.00067.2023","volume":"325","author":"DL Kirkman","year":"2023","unstructured":"Kirkman, D. L. et al. Effects of a mitochondrial-targeted ubiquinol on vascular function and exercise capacity in chronic kidney disease: a randomized controlled pilot study. Am. J. Physiol. Ren. Physiol. 325, F448\u2013F456 https:\/\/doi.org\/10.1152\/ajprenal.00067.2023 (2023).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1127_CR213","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","volume":"2","author":"SA Mortensen","year":"2014","unstructured":"Mortensen, S. A. et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure. JACC: Heart Fail. 2, 641\u2013649 https:\/\/doi.org\/10.1016\/j.jchf.2014.06.008 (2014).","journal-title":"JACC: Heart Fail."},{"key":"1127_CR214","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/bph.12461","volume":"171","author":"HH Szeto","year":"2014","unstructured":"Szeto, H. H. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br. J. Pharmacol. 171, 2029\u20132050 https:\/\/doi.org\/10.1111\/bph.12461 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"1127_CR215","unstructured":"FDA grants accelerated approval to first treatment for Barth syndrome. US Food and Drug Administration https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-grants-accelerated-approval-first-treatment-barth-syndrome (2025)."},{"key":"1127_CR216","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005487","volume":"10","author":"A Saad","year":"2017","unstructured":"Saad, A. et al. Phase 2a clinical trial of mitochondrial protection (elamipretide) during stent revascularization in patients with atherosclerotic renal artery stenosis. Circ. Cardiovasc. Interv. 10, e005487 https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.005487 (2017).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"1127_CR217","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03421-7","volume":"9","author":"CR Martens","year":"2018","unstructured":"Martens, C. R. et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults. Nat. Commun. 9, 1286 https:\/\/doi.org\/10.1038\/s41467-018-03421-7 (2018).","journal-title":"Nat. Commun."},{"key":"1127_CR218","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.abe9985","volume":"372","author":"M Yoshino","year":"2021","unstructured":"Yoshino, M. et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 372, 1224\u20131229 https:\/\/doi.org\/10.1126\/science.abe9985 (2021).","journal-title":"Science"},{"key":"1127_CR219","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","volume":"28","author":"YS Elhassan","year":"2019","unstructured":"Elhassan, Y. S. et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 28, 1717\u20131728\u00a0https:\/\/doi.org\/10.1016\/j.celrep.2019.07.043 (2019).","journal-title":"Cell Rep."},{"key":"1127_CR220","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.167274","volume":"8","author":"A Ahmadi","year":"2023","unstructured":"Ahmadi, A. et al. Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease. JCI Insight 8, e167274 https:\/\/doi.org\/10.1172\/jci.insight.167274 (2023).","journal-title":"JCI Insight"},{"key":"1127_CR221","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/ajcn\/nqaa072","volume":"112","author":"CME Remie","year":"2020","unstructured":"Remie, C. M. E. et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. Am. J. Clin. Nutr. 112, 413\u2013426 https:\/\/doi.org\/10.1093\/ajcn\/nqaa072 (2020).","journal-title":"Am. J. Clin. Nutr."},{"key":"1127_CR222","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.jacbts.2022.06.012","volume":"7","author":"DD Wang","year":"2022","unstructured":"Wang, D. D. et al. Safety and tolerability of nicotinamide riboside in heart failure with reduced ejection fraction. JACC Basic Transl. Sci. 7, 1183\u20131196 https:\/\/doi.org\/10.1016\/j.jacbts.2022.06.012 (2022).","journal-title":"JACC Basic Transl. Sci."},{"key":"1127_CR223","doi-asserted-by":"publisher","first-page":"H966","DOI":"10.1152\/ajpheart.00883.2012","volume":"304","author":"A Masuzawa","year":"2013","unstructured":"Masuzawa, A. et al. Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 304, H966\u2013H982 https:\/\/doi.org\/10.1152\/ajpheart.00883.2012 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1127_CR224","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41581-026-01072-2","volume":"22","author":"JD McCully","year":"2026","unstructured":"McCully, J. D., Celik, A., Asthana, A. & Orlando, G. Therapeutic and mechanistic insights on mitochondrial transplantation in kidney disease. Nat. Rev. Nephrol. 22, 459\u2013473 https:\/\/doi.org\/10.1038\/s41581-026-01072-2 (2026).","journal-title":"Nat. Rev. Nephrol."},{"key":"1127_CR225","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jtcvs.2017.02.018","volume":"154","author":"SM Emani","year":"2017","unstructured":"Emani, S. M., Piekarski, B. L., Harrild, D., Del Nido, P. J. & McCully, J. D. Autologous mitochondrial transplantation for dysfunction after ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 154, 286\u2013289 https:\/\/doi.org\/10.1016\/j.jtcvs.2017.02.018 (2017).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"1127_CR226","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02851758 (2026)."},{"key":"1127_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00325","volume":"21","author":"BJ Shayota","year":"2024","unstructured":"Shayota, B. J. Biomarkers of mitochondrial disorders. Neurotherapeutics 21, e00325 https:\/\/doi.org\/10.1016\/j.neurot.2024.e00325 (2024).","journal-title":"Neurotherapeutics"},{"key":"1127_CR228","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02656-1","volume":"24","author":"A Mengozzi","year":"2025","unstructured":"Mengozzi, A. et al. Circulating mitochondrial DNA signature in cardiometabolic patients. Cardiovasc. Diabetol. 24, 106 https:\/\/doi.org\/10.1186\/s12933-025-02656-1 (2025).","journal-title":"Cardiovasc. Diabetol."},{"key":"1127_CR229","doi-asserted-by":"publisher","first-page":"12278","DOI":"10.1096\/fj.202000959RR","volume":"34","author":"HS Rosa","year":"2020","unstructured":"Rosa, H. S., Ajaz, S., Gnudi, L. & Malik, A. N. A case for measuring both cellular and cell-free mitochondrial DNA as a disease biomarker in human blood. FASEB J. 34, 12278\u201312288 https:\/\/doi.org\/10.1096\/fj.202000959RR (2020).","journal-title":"FASEB J."},{"key":"1127_CR230","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6520","volume":"364","author":"W Wei","year":"2019","unstructured":"Wei, W. et al. Germline selection shapes human mitochondrial DNA diversity. Science 364, eaau6520 https:\/\/doi.org\/10.1126\/science.aau6520 (2019).","journal-title":"Science"},{"key":"1127_CR231","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S2213-8587(20)30369-7","volume":"9","author":"DC Wheeler","year":"2021","unstructured":"Wheeler, D. C. et al. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol. 9, 22\u201331 https:\/\/doi.org\/10.1016\/S2213-8587(20)30369-7 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1127_CR232","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic, V. et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N. Engl. J. Med. 380, 2295\u20132306 https:\/\/doi.org\/10.1056\/NEJMoa1811744 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1127_CR233","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S2213-8587(20)30162-5","volume":"8","author":"DZI Cherney","year":"2020","unstructured":"Cherney, D. Z. I. et al. Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial. Lancet Diabetes Endocrinol. 8, 582\u2013593 https:\/\/doi.org\/10.1016\/S2213-8587(20)30162-5 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1127_CR234","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa2030186","volume":"384","author":"DL Bhatt","year":"2021","unstructured":"Bhatt, D. L. et al. Sotagliflozin in patients with diabetes and chronic kidney disease. N. Engl. J. Med. 384, 129\u2013139 https:\/\/doi.org\/10.1056\/NEJMoa2030186 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1127_CR235","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S2213-8587(20)30313-2","volume":"8","author":"JFE Mann","year":"2020","unstructured":"Mann, J. F. E. et al. Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials. Lancet Diabetes Endocrinol. 8, 880\u2013893 https:\/\/doi.org\/10.1016\/S2213-8587(20)30313-2 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1127_CR236","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","volume":"13","author":"SV Badve","year":"2025","unstructured":"Badve, S. V. et al. Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 13, 15\u201328 https:\/\/doi.org\/10.1016\/S2213-8587(24)00271-7 (2025).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1127_CR237","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jacc.2024.10.091","volume":"85","author":"FR Mc Causland","year":"2025","unstructured":"Mc Causland, F. R. et al. Finerenone and kidney outcomes in patients with heart failure: the FINEARTS-HF trial. J. Am. Coll. Cardiol. 85, 159\u2013168 https:\/\/doi.org\/10.1016\/j.jacc.2024.10.091 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1127_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101138","volume":"26","author":"WR Thompson","year":"2024","unstructured":"Thompson, W. R. et al. Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER. Genet. Med. 26, 101138 https:\/\/doi.org\/10.1016\/j.gim.2024.101138 (2024).","journal-title":"Genet. Med."},{"key":"1127_CR239","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/eurheartj\/ehv597","volume":"37","author":"CM Gibson","year":"2016","unstructured":"Gibson, C. M. et al. EMBRACE STEMI study: a phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention. Eur. Heart J. 37, 1296\u20131303 https:\/\/doi.org\/10.1093\/eurheartj\/ehv597 (2016).","journal-title":"Eur. Heart J."},{"key":"1127_CR240","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cardfail.2020.02.001","volume":"26","author":"J Butler","year":"2020","unstructured":"Butler, J. et al. Effects of elamipretide on left ventricular function in patients with heart failure with reduced ejection fraction: the PROGRESS-HF phase 2 trial. J. Card. Fail. 26, 429\u2013437 https:\/\/doi.org\/10.1016\/j.cardfail.2020.02.001 (2020).","journal-title":"J. Card. Fail."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01127-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01127-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01127-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:03:19Z","timestamp":1790247799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01127-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":240,"alternative-id":["1127"],"URL":"https:\/\/doi.org\/10.1038\/s41581-026-01127-4","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"27 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}